Clinical Trials on Niemann-Pick Disease, Type C in Russian Federation
Total 1169 results
-
Kartos Therapeutics, Inc.RecruitingChronic Myeloid LeukemiaItaly, Spain, United States, Korea, Republic of, France, Poland, Canada, Russian Federation
-
Active Biotech ABCompletedRenal Cell CarcinomaRomania, Russian Federation, United Kingdom, Ukraine, Bulgaria
-
PhenomixForest LaboratoriesTerminatedType 2 Diabetes Mellitus | Renal ImpairmentUnited States, Russian Federation, Ukraine
-
Debiopharm International SACompletedHepatitis CRomania, Italy, Belgium, Germany, Hungary, Taiwan, Spain, Australia, Hong Kong, Thailand, France, United States, United Kingdom, Turkey, Argentina, Russian Federation, India, Korea, Republic of, Vietnam, Poland, Mexico, Canada
-
SanofiTerminatedSleep Initiation and Maintenance DisordersUnited States, Canada, Brazil, Russian Federation, Australia, Germany, Italy, Spain, Turkey, India, Malaysia, Singapore, Belgium, Czech Republic, Mexico, Argentina, Austria, Colombia, Chile, South Africa, United Kingdom, Hong Kong
-
Fondazione MichelangeloCompletedInvasive Ductal Breast CarcinomaSpain, Ireland, Italy, Taiwan, Germany, Austria, Russian Federation
-
Bristol-Myers SquibbWithdrawnAcute Lymphoblastic Leukemia | Chronic Myeloid LeukemiaNetherlands, Italy, United Kingdom, Russian Federation, Poland, Hungary
-
AstraZenecaParexel; PRA Health Sciences; Q2 Solutions; Covance Laboratories, IncCompletedType 2 DiabetesUnited States, Israel, Hungary, Russian Federation, Mexico, Romania, United Kingdom
-
Novo Nordisk A/SCompletedDiabetes | Diabetes Mellitus, Type 1France, Denmark, Finland, Russian Federation, Macedonia, The Former Yugoslav Republic of, Hungary, Bulgaria, United Kingdom, Turkey, Czech Republic, Poland
-
Hoffmann-La RocheCompletedDiabetes Mellitus Type 2Australia, Hong Kong, Spain, United States, Mexico, Russian Federation, Guatemala, United Kingdom, Brazil
-
SecuraBioCompletedIndolent Non-Hodgkin LymphomaKorea, Republic of, Czechia, United States, United Kingdom, Italy, Poland, Russian Federation, Germany
-
Eli Lilly and CompanyCompletedDiabetes Mellitus, Type 2Russian Federation, Puerto Rico, United States, Australia, Hungary, Poland, Romania, Spain
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesSaudi Arabia, Algeria, Argentina, Bangladesh, China, Egypt, India, Indonesia, Iran, Islamic Republic of, Jordan, Korea, Republic of, Libyan Arab Jamahiriya, Malaysia, Mexico, Morocco, Pakistan, Philippines, Russian Federation and more
-
SanofiCompletedDiabetes Mellitus, Type 2Algeria, Colombia, Egypt, Guatemala, India, Iran, Islamic Republic of, Lebanon, Mexico, Russian Federation, South Africa, Tunisia, Turkey, Ukraine, United Arab Emirates
-
Debiopharm International SACompletedHepatitis CUnited States, Romania, Belgium, Germany, Hungary, Taiwan, Spain, Italy, Australia, France, Hong Kong, Thailand, Korea, Republic of, United Kingdom, Argentina, Russian Federation, Canada, Poland, Puerto Rico, Vietnam, Mexico
-
Boehringer IngelheimCompletedLymphoma, FollicularSpain, Belgium, Czechia, France, Croatia, Germany, Austria, New Zealand, Australia, Greece, Hungary, Poland, Russian Federation
-
GlaxoSmithKlineCompletedDiabetes Mellitus, Type 2Korea, Republic of, Malaysia, Philippines, Thailand, Russian Federation, Mexico
-
Astellas Pharma IncActive, not recruitingAcute Myeloid Leukemia With FMS-like Tyrosine Kinase (FLT3) MutationChina, Malaysia, Russian Federation, Singapore, Thailand
-
Eli Lilly and CompanyCompletedDiabetes Mellitus, Type 1Russian Federation, United States, Australia, Greece, Argentina, Hungary, Brazil, Mexico, Romania
-
Seagen Inc.Millennium Pharmaceuticals, Inc.No longer availableLymphoma, Non-Hodgkin | Lymphoma, T-Cell, Cutaneous | Lymphoma, Large-Cell, Anaplastic | Disease, HodgkinUnited States, United Kingdom, Belgium, Serbia, Australia, Bulgaria, France, Germany, Hungary, Italy, Poland, Romania, Russian Federation, Spain, Switzerland
-
Astellas Pharma Global Development, Inc.CompletedCLDN18.2-positive Adenocarcinoma of the Gastroesophageal Junction | CLDN18.2-positive Adenocarcinoma of Esophagus | CLDN18.2-positive Gastric AdenocarcinomaBulgaria, Czechia, Germany, Latvia, Russian Federation, Ukraine
-
FeRxTerminatedCarcinoma, HepatocellularUnited States, Austria, Thailand, Germany, Ukraine, United Kingdom, Hong Kong, Russian Federation
-
Hoffmann-La RocheCompletedOvarian CancerBelgium, Spain, Canada, Russian Federation, United Kingdom, Hungary, Italy, Poland, Netherlands
-
GlaxoSmithKlineTerminatedLiver Diseases | HIV Infection | Thrombocytopenia | Hepatitis C Virus | HBV | NASH - Nonalcoholic Steatohepatitis | Human Immunodeficiency Virus | Chronic Liver Disease | HCV | Non-alcoholic Steatohepatitis | Hepatitis B VirusUnited States, Spain, Taiwan, Italy, Belgium, France, Korea, Republic of, Canada, Russian Federation, Pakistan, Poland, India, Argentina
-
Hoffmann-La RocheRecruitingNeoplasmsItaly, France, Turkey, Korea, Republic of, Spain, China, United States, Hong Kong, Russian Federation, Poland
-
SanofiCompletedType 1 Diabetes MellitusUnited States, Austria, Brazil, Chile, Czech Republic, Germany, Hungary, India, Mexico, Peru, Poland, Romania, Russian Federation, South Africa, Spain, Turkey
-
BayerCompletedCarcinoma, HepatocellularHong Kong, Canada, Russian Federation, United States, Argentina, United Kingdom
-
Pfizer's Upjohn has merged with Mylan to form Viatris...CompletedDiabetes Mellitus, Type 2 | Dyslipidemia | Peripheral Vascular Disease | Coronary Arteriosclerosis | Cerebrovascular AccidentGreece, Ireland, Russian Federation, Slovakia, Poland, Hungary, Portugal, Switzerland
-
Novartis PharmaceuticalsCompletedGastrointestinal Stromal TumorsSaudi Arabia, Taiwan, Turkey, Egypt, Thailand, Russian Federation, South Africa, Lebanon, India, Tunisia, Algeria, Jordan
-
SanofiRegeneron PharmaceuticalsCompletedHypercholesterolaemiaNetherlands, United States, Canada, Russian Federation, South Africa
-
R-PharmData Management 365; Exacte Labs LLC; Federal State Budgetary Institution of...Active, not recruitingSkin MelanomaRussian Federation
-
Lexicon PharmaceuticalsSanofiTerminatedType 2 Diabetes MellitusUnited States, Australia, Canada, Korea, Republic of, Mexico, New Zealand, Russian Federation, Taiwan
-
ShireCompletedGaucher Disease, Type 1United States, Israel, Argentina, India, Korea, Republic of, Paraguay, Poland, Russian Federation, Spain, Tunisia, United Kingdom
-
Federal Research Institute of Pediatric Hematology...UnknownChildhood Acute Lymphoblastic LeukemiaRussian Federation, Belarus, Uzbekistan
-
Hoffmann-La RocheCompletedDiabetes Mellitus Type 2Italy, Hong Kong, Romania, Greece, United States, Mexico, Serbia, Russian Federation
-
Novartis PharmaceuticalsCompletedType 2 Diabetes MellitusEgypt, United Kingdom, Turkey, Lebanon, Russian Federation, Tunisia, Malaysia, Germany, Spain, Saudi Arabia, Denmark, Indonesia, Jordan, Kuwait, Singapore, United Arab Emirates
-
Sirtris, a GSK CompanyGlaxoSmithKlineCompletedDiabetes Mellitus, Type 2Bulgaria, Estonia, Russian Federation, Ukraine, United Kingdom, Hungary, Poland, Romania
-
AmgenTerminatedAdenocarcinoma of the Pancreas | Locally Advanced | UnresectableSpain, Belgium, Denmark, Poland, United States, Korea, Republic of, Russian Federation, Austria, Portugal, United Kingdom, Germany, Hungary, Czech Republic
-
Human Genome Sciences Inc., a GSK CompanyGlaxoSmithKlineCompletedCarcinoma, HepatocellularPuerto Rico, United States, Germany, Ukraine, Russian Federation, Poland, Romania
-
BayerCompletedLiver NeoplasmsUnited States, Canada, Japan, Spain, Sweden, Belgium, Argentina, Austria, Greece, Italy, Korea, Republic of, Netherlands, Russian Federation, Taiwan, Turkey, China, Denmark, Egypt, France, Saudi Arabia, Thailand
-
QED Therapeutics, Inc.Helsinn Healthcare SATerminatedFGFR2 Gene Mutation | Advanced CholangiocarcinomaUnited States, Belgium, Germany, Italy, Korea, Republic of, Russian Federation, Singapore, Spain, Taiwan, Thailand, United Kingdom
-
Hoffmann-La RocheCompletedDiabetes Mellitus Type 2Australia, Mexico, Taiwan, United States, Israel, Russian Federation, Slovakia, Ukraine, Guatemala, Peru, Romania
-
Eli Lilly and CompanyWithdrawnDiabetes Mellitus, Type 2United States, Spain, Poland, Austria, Germany, Czech Republic, Russian Federation
-
Novartis PharmaceuticalsCompletedMedulloblastomaFrance, Spain, Germany, Italy, Netherlands, United Kingdom, Canada, Australia, Sweden, United States, Brazil, Switzerland, Russian Federation
-
Novartis PharmaceuticalsTerminatedGastrointestinal Stromal TumorsChina, Argentina, Russian Federation, Thailand, Korea, Republic of, Brazil, Canada, Venezuela, Mexico
-
SanofiCompletedType 1 Diabetes Mellitus-Type 2 Diabetes MellitusHungary, Russian Federation, Germany, Poland, Japan, United States, Finland
-
Novartis PharmaceuticalsActive, not recruitingHematologic Diseases | Chronic Myelogenous Leukemia | CML | Leukemia, Myeloid ChronicTaiwan, Italy, Spain, United Kingdom, Germany, United States, Korea, Republic of, France, Russian Federation, Canada, Denmark, Poland, Portugal, Austria, Czechia
-
Boehringer IngelheimCompletedDiabetes Mellitus, Type 2United States, Canada, Mexico, Philippines, Romania, Russian Federation, Ukraine
-
Hoffmann-La RocheCompletedDiabetes Mellitus Type 2Australia, Hong Kong, Romania, United States, Japan, Russian Federation, Spain, Canada, Germany, Latvia, Mexico, Brazil
-
Novo Nordisk A/SCompletedDiabetes | Diabetes Mellitus, Type 1France, Denmark, Finland, Russian Federation, Macedonia, The Former Yugoslav Republic of, Hungary, Bulgaria, United Kingdom, Turkey, Poland, Czech Republic